Sort
48,018 grants matching “immunotherapy”
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
$632,109Nicholas C Denko · Ohio State University · R01 · FY2022 · CA
Tissue Cytokine Sequestration and Immune Regulation in Autoimmunity
$632,042Paul L Bollyky · Stanford University · U01 · FY2017 · AI
Tissue Cytokine Sequestration and Immune Regulation in Autoimmunity
$632,042Paul L Bollyky · Stanford University · U01 · FY2019 · AI
Tissue Cytokine Sequestration and Immune Regulation in Autoimmunity
$632,042Paul L Bollyky · Stanford University · U01 · FY2021 · AI
Tissue Cytokine Sequestration and Immune Regulation in Autoimmunity
$632,042Paul L Bollyky · Stanford University · U01 · FY2020 · AI
Mechanisms of Durable Antitumor Immunity Mediated by PI3K-targeted T cells
$632,039Chrystal Mary Paulos · Emory University · R01 · FY2025 · CA
Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer
$632,011Maximilian Diehn · Stanford University · R01 · FY2021 · CA
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
$631,958Cristian T Badea · Duke University · U24 · FY2018 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$631,889Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA
Long-Term Cardiovascular Sequelae of Cancer Immunotherapies
$631,885Javid J Moslehi · University Of California, San Francisco · R01 · FY2022 · HL
Developing an Oncology Workforce for the 21st Century
$631,864Olufunmilayo I Olopade · University Of Chicago · K12 · FY2022 · CA
Targeting dsRNA sensing and ADAR1 in melanoma
$631,778Jeffrey J. Ishizuka · Yale University · R37 · FY2025 · CA
Targeting dsRNA sensing and ADAR1 in melanoma
$631,778Jeffrey J. Ishizuka · Yale University · R37 · FY2024 · CA
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)
$631,711Gregory R J Thatcher · University Of Arizona · R01 · FY2025 · CA
Rational translation of gold nanoparticle mediated radiosensitization tothe clinic
$631,688Sunil Krishnan · Mayo Clinic Jacksonville · R01 · FY2021 · CA
Training Program in Basic Cancer Research
$631,576Wistar Institute · T32 · FY2003 · CA
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy
$631,543Karl T Kelsey · Brown University · R01 · FY2024 · CA
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
$631,495Gerald S Shadel · Salk Institute For Biological Studies · R01 · FY2019 · CA
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
$631,432John H Sampson · Duke University · P01 · FY2021 · CA
Project 2: Elucidating how TIGIT agonists regulate CNS autoimmunity exacerbated by PD-1 blockade
$631,388Arlene H Sharpe · Yale University · P01 · FY2025 · AI
Project 2: Elucidating how TIGIT agonists regulate CNS autoimmunity exacerbated by PD-1 blockade
$631,388Arlene H Sharpe · Yale University · P01 · FY2023 · AI
Project 2: Elucidating how TIGIT agonists regulate CNS autoimmunity exacerbated by PD-1 blockade
$631,388Arlene H Sharpe · Yale University · P01 · FY2024 · AI
Regulatory dendritic cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
$631,385Angus W Thomson · University Of Pittsburgh At Pittsburgh · U19 · FY2019 · AI
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
$631,336Arvin Dar · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Dissecting the tumor-intrinsic and -extrinsic roles of TBK1 in tumor immunity
$631,104Russell William Jenkins · Massachusetts General Hospital · R37 · FY2023 · CA